US 12,275,934 B2
Strain of Lactobacillus rhamnosus and application thereof in inhibiting Helicobacter pylori
Qixiao Zhai, Wuxi (CN); Wei Chen, Wuxi (CN); Jianxin Zhao, Wuxi (CN); Meiyi Zhang, Wuxi (CN); Shumao Cui, Wuxi (CN); Wenwei Lu, Wuxi (CN); Fengwei Tian, Wuxi (CN); Leilei Yu, Wuxi (CN); Gang Wang, Wuxi (CN); and Hao Zhang, Wuxi (CN)
Assigned to Jiangnan University, Wuxi (CN)
Filed by Jiangnan University, Wuxi (CN)
Filed on Apr. 1, 2022, as Appl. No. 17/711,257.
Application 17/711,257 is a continuation of application No. PCT/CN2021/095678, filed on May 25, 2021.
Claims priority of application No. 202010478076.0 (CN), filed on May 29, 2020.
Prior Publication US 2022/0228106 A1, Jul. 21, 2022
Int. Cl. C12N 1/20 (2006.01); A23L 33/00 (2016.01); A23L 33/135 (2016.01); A61K 35/747 (2015.01); A61P 31/04 (2006.01); C12R 1/225 (2006.01)
CPC C12N 1/205 (2021.05) [A23L 33/135 (2016.08); A23L 33/40 (2016.08); A61K 35/747 (2013.01); A61P 31/04 (2018.01); A23V 2002/00 (2013.01); A23V 2400/175 (2023.08); C12R 2001/225 (2021.05)] 5 Claims
 
1. A Helicobacter pylori inhibitor, comprising Lactobacillus rhamnosus,
wherein the Helicobacter pylori is Helicobacter pylori SS1;
wherein the Lactobacillus rhamnosus is preserved in the Guangdong Microbial Culture Collection Center, under the preservation number GDMCC NO: 61013, on May 6, 2020; and
wherein the inhibitor is a food or a medicine.